FourThought Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$244K Buy
537
+129
+32% +$61.7K 0.04% 272
2022
Q2
$197K Hold
408
0.03% 314
2022
Q1
$200K Hold
408
0.03% 339
2021
Q4
$189K Hold
408
0.02% 351
2021
Q3
$152K Hold
408
0.02% 389
2021
Q2
$155K Hold
408
0.02% 396
2021
Q1
$146K Sell
408
-200
-33% -$64.3K 0.02% 410
2020
Q4
$195K Buy
+608
New +$187K 0.03% 344

Other funds holding ELV

FourThought Financial's ELV Position: Q3 2022 in Review

FourThought Financial increased its Elevance Health (ELV) stake by 32% in Q3 2022, buying an estimated $61.7K and bringing the position to 537 shares worth $244K. The position accounts for 0.04% of the portfolio, ranked #272.

FourThought Financial first reported a position in ELV in Q4 2020 and has held it in 8 quarters since. 1,446 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • FourThought Financial held 537 shares of Elevance Health worth $244K as of Q3 2022.
  • FourThought Financial bought 129 Elevance Health shares in Q3 2022, an estimated $61.7K.
  • Elevance Health made up 0.04% of FourThought Financial's portfolio in Q3 2022, its #272 holding.
  • FourThought Financial first reported a position in Elevance Health in Q4 2020 and has held it in 8 quarters since.
  • 1,446 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.